A few months ago, the father of marijuana research, Professor Raphael Mechoulam, unveiled his newest discovery: the cannabidiolic acid (EPM 301). His introduction of the latest, patented substance caused much excitement in the marijuana industry, especially within the medical cannabis sector. His compound is entirely stable, synthetic, and an acid-based cannabinoid molecule. It was announced to the world in collaboration with EPM, a global biotechnology company in America. EPM seeks to bridge the gap between the pharmaceutical industry and the cannabis market.
The incident involving Cost Cannabis in Revelstoke, British Columbia, raises significant questions about pricing strategies…
He emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from…
"How Long Does One Puff of Weed Stay in Your System?"... This topic can be difficult…
GMO x Purple Punch deliver a knockout. The post Sleep through it all with Modified…
As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its…
An intriguing trend has emerged In recent years within the world of professional golf: a…